Cleared Traditional

K912179 - THE SPRITZ BATH

K912179 is an FDA 510(k) clearance for THE SPRITZ BATH, manufactured by The Spritz Co.. The device is a Class 1 Physical Medicine device with product code KTC cleared through the Traditional 510(k) pathway after a 104-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1991
Decision
104d
Days
Class 1
Risk

K912179 is an FDA 510(k) clearance for the THE SPRITZ BATH. Classified as Bath, Sitz, Nonpowered (product code KTC), Class I - General Controls.

Submitted by The Spritz Co. (Houston, US). The FDA issued a Cleared decision on August 28, 1991 after a review of 104 days - within the typical 510(k) review window.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5125 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

View all The Spritz Co. devices

FDA 510(k) Submission Details - K912179

510(k) Number K912179 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 16, 1991
Decision Date August 28, 1991
Days to Decision 104 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
11d faster than avg
Panel avg: 115d · This submission: 104d
Pathway characteristics
Predicate-based equivalence.

KTC Device Classification - Class 1, General Controls

Product Code KTC Bath, Sitz, Nonpowered
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 890.5125
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.